Gene · 2822
Papers4,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Exploratory Study of Peripheral Vestibular System in Users of Personal Listening Devices. | J Audiol Otol | 2025 | 39916397 | PubTator, text mining | PubMed |
| A parametric bootstrap control chart for Lindley Geometric percentiles. | PLoS One | 2025 | 39913474 | PubTator, text mining | PubMed |
| ATP Binding and Inhibition of Intrinsically Disordered Protein Interactions. | Langmuir | 2025 | 39885825 | PubTator, text mining | PubMed |
| Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk. | Schizophrenia (Heidelb) | 2025 | 39863625 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| Hearing thresholds at conventional and extended high frequencies in young personal listening devices' users: A pilot study. | Otolaryngol Pol | 2025 | 39812308 | PubTator, text mining | PubMed |
| Proteomic Analysis of Plasma Exosomes Enables the Identification of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease. | Thorac Cancer | 2025 | 39778061 | PubTator, text mining | PubMed |
| Associations between physical activity, brain health, cognitive function, and circulating GPLD1 in healthy older (65-85 years) individuals. | Geroscience | 2025 | 39762691 | PubTator, text mining | PubMed |
| GPLD1+ cancer stem cells contribute to chemotherapy resistance and tumour relapse in intestinal cancer. | J Biochem | 2025 | 39743241 | PubTator, text mining | PubMed |
| Phosphatidic acid as a cofactor of mTORC1 in platinum-based chemoresistance: Mechanisms and therapeutic potential. | Eur J Pharmacol | 2025 | 39716566 | PubTator, text mining | PubMed |
| Multi-Omics Analyses Offer Novel Insights into the Selection of Sugar and Lipid Metabolism During Maize Domestication and Improvement. | Plant Cell Environ | 2025 | 39601310 | PubTator, text mining | PubMed |
| Risky leisure noise exposure during the transition to adulthood and the impact of major life events - results of the OHRKAN cohort study. | Int J Audiol | 2025 | 39535123 | PubTator, text mining | PubMed |
| Phospholipase D2 downregulates interleukin-1β secretion from tumor-associated macrophages to suppress bladder cancer progression. | Cancer Sci | 2025 | 39528232 | PubTator, text mining | PubMed |
| Inhibition of phospholipase D1 reduces pancreatic carcinogenesis in mice partly through a FAK-dependent mechanism. | Carcinogenesis | 2025 | 39487573 | PubTator, text mining | PubMed |
| Phase-Specific Immobilization of Phospholipase D as an Efficient Pickering Emulsion Interfacial Catalyst for Converting Antarctic Krill Oil Phospholipid. | ACS Appl Mater Interfaces | 2025 | 39420812 | PubTator, text mining | PubMed |
| PILS-Nir1 is a novel phosphatidic acid biosensor that reveals mechanisms of lipid production. | bioRxiv | 2025 | 38464273 | PubTator, text mining | PubMed |
| Prevalence of High Frequency Noise-Induced Hearing Loss Among Medical Students Using Personalized Listening Devices. | J Clin Med | 2024 | 39797131 | PubTator, text mining | PubMed |
| Second-Generation Antipsychotics Induce Metabolic Disruption in Adipose Tissue-Derived Mesenchymal Stem Cells Through an aPKC-Dependent Pathway. | Cells | 2024 | 39768174 | PubTator, text mining | PubMed |
| A Progressive Loss Decomposition Method for Low-Frequency Shielding of Soft Magnetic Materials. | Materials (Basel) | 2024 | 39597406 | PubTator, text mining | PubMed |
| SHIMP Findings in Individuals Using Personal Listening Devices. | Indian J Otolaryngol Head Neck Surg | 2024 | 39559044 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2822/papers?page=8